๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—† Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—†
Updated 04 Jul 2026 ยท HPRA open data

Insulin human - Medicines in Ireland

49 authorised products containing Insulin human, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
Showing 49 authorised medicines
MedicineActive substanceLicence holderStatus
Actraphane
EU/1/02/229/001-035
Insulin human Novo Nordisk A/S โ€”
Actraphane 30 40 IU/ml Suspension for injection
EU/1/02/229/036-037
Insulin human, Insulin human Novo Nordisk A/S โ€”
Actrapid
EU/1/02/230/001-015
Insulin human Novo Nordisk A/S โ€”
Actrapid
EU/1/02/230/016-017
Insulin human Novo Nordisk A/S โ€”
Insulatard
EU/1/02/233/1-15
Insulin human Novo Nordisk A/S โ€”
Insulatard 100 international units/ml suspension for injection in vial
EU/1/02/233/003-004
Insulin human Novo Nordisk A/S โ€”
Insulatard FlexPen
EU/1/02/233/013
Insulin human Novo Nordisk A/S โ€”
Insulatard InnoLet
EU/1/02/233/010-012
Insulin human Novo Nordisk A/S โ€”
Insulatard Penfill
EU/1/02/233/005-007
Insulin human Novo Nordisk A/S โ€”
Insuman Basal 100 IU/ml suspension for injection in a cartridge
EU/1/97/030/035
Insulin human Sanofi-Aventis Deutschland GmbH โ€”
Insuman Basal 100 IU/ml suspension for injection in a cartridge
EU/1/97/030/057
Insulin human Sanofi-Aventis Deutschland GmbH โ€”
Insuman Basal 100 IU/ml suspension for injection in a cartridge
EU/1/97/030/058
Insulin human Sanofi-Aventis Deutschland GmbH โ€”
Insuman Basal 100 IU/ml suspension for injection in a vial
EU/1/97/030/033
Insulin human Sanofi-Aventis Deutschland GmbH โ€”
Insuman Basal 100 IU/ml suspension for injection in a vial
EU/1/97/030/034
Insulin human Sanofi-Aventis Deutschland GmbH โ€”
Insuman Basal 40 IU/ml suspension for injection in a vial
EU/1/97/030/036
Insulin human Sanofi-Aventis Deutschland GmbH โ€”
Insuman Basal 40 IU/ml suspension for injection in a vial
EU/1/97/030/037
Insulin human Sanofi-Aventis Deutschland GmbH โ€”
Insuman Comb 15 100 IU/ml suspension for injection in a cartridge
EU/1/97/030/040
Insulin human Sanofi-Aventis Deutschland GmbH โ€”
Insuman Comb 15 100 IU/ml suspension for injection in a cartridge
EU/1/97/030/059
Insulin human Sanofi-Aventis Deutschland GmbH โ€”
Insuman Comb 15 100 IU/ml suspension for injection in a cartridge
EU/1/97/030/060
Insulin human Sanofi-Aventis Deutschland GmbH โ€”
Insuman Comb 15 100 IU/ml suspension for injection in a vial
EU/1/97/030/038
Insulin human Sanofi-Aventis Deutschland GmbH โ€”
Insuman Comb 15 100 IU/ml suspension for injection in a vial
EU/1/97/030/039
Insulin human Sanofi-Aventis Deutschland GmbH โ€”
Insuman Comb 25 100 IU/ml suspension for injection in a cartridge
EU/1/97/030/045
Insulin human Sanofi-Aventis Deutschland GmbH โ€”
Insuman Comb 25 100 IU/ml suspension for injection in a cartridge
EU/1/97/030/061
Insulin human Sanofi-Aventis Deutschland GmbH โ€”
Insuman Comb 25 100 IU/ml suspension for injection in a cartridge
EU/1/97/030/062
Insulin human Sanofi-Aventis Deutschland GmbH โ€”
Insuman Comb 25 100 IU/ml suspension for injection in a vial
EU/1/97/030/043
Insulin human Sanofi-Aventis Deutschland GmbH โ€”
Insuman Comb 25 100 IU/ml suspension for injection in a vial
EU/1/97/030/044
Insulin human Sanofi-Aventis Deutschland GmbH โ€”
Insuman Comb 25 40IU/ml
EU/1/97/030/046
Insulin human Sanofi-Aventis Deutschland GmbH โ€”
Insuman Comb 25 40IU/ml
EU/1/97/030/047
Insulin human Sanofi-Aventis Deutschland GmbH โ€”
Insuman Comb 50 100 IU/ml suspension for injection in a cartridge
EU/1/97/030/063
Insulin human Sanofi-Aventis Deutschland GmbH โ€”
Insuman Comb 50 100 IU/ml suspension for injection in a cartridge
EU/1/97/030/064
Insulin human Sanofi-Aventis Deutschland GmbH โ€”
Insuman Comb 50 100IU/ml
EU/1/97/030/048
Insulin human Sanofi-Aventis Deutschland GmbH โ€”
Insuman Comb 50 100IU/ml
EU/1/97/030/049
Insulin human Sanofi-Aventis Deutschland GmbH โ€”
Insuman Comb 50 100IU/ml
EU/1/97/030/050
Insulin human Sanofi-Aventis Deutschland GmbH โ€”
Insuman Comb 50 40IU/ml
EU/1/97/030/051
Insulin human Sanofi-Aventis Deutschland GmbH โ€”
Insuman Comb 50 40IU/ml
EU/1/97/030/052
Insulin human Sanofi-Aventis Deutschland GmbH โ€”
Insuman Implantable 400 IU/ml solution for infusion
EU/1/97/030/202-203
Insulin human Sanofi-Aventis Deutschland GmbH โ€”
Insuman Infusat 100IU/ml
EU/1/97/030/053
Insulin human Sanofi-Aventis Deutschland GmbH โ€”
Insuman Infusat 100IU/ml
EU/1/97/030/054
Insulin human Sanofi-Aventis Deutschland GmbH โ€”
Insuman Rapid 100 IU/ml solution for injection in a cartridge
EU/1/97/030/030
Insulin human Sanofi-Aventis Deutschland GmbH โ€”
Insuman Rapid 100 IU/ml solution for injection in a cartridge
EU/1/97/030/055
Insulin human Sanofi-Aventis Deutschland GmbH โ€”
Insuman Rapid 100 IU/ml solution for injection in a cartridge
EU/1/97/030/056
Insulin human Sanofi-Aventis Deutschland GmbH โ€”
Insuman Rapid 100 IU/ml solution for injection in a vial
EU/1/97/030/028
Insulin human Sanofi-Aventis Deutschland GmbH โ€”
Insuman Rapid 100 IU/ml solution for injection in a vial
EU/1/97/030/029
Insulin human Sanofi-Aventis Deutschland GmbH โ€”
Insuman Rapid 40 IU/ml solution for injection in a vial
EU/1/97/030/031
Insulin human Sanofi-Aventis Deutschland GmbH โ€”
Insuman Rapid 40 IU/ml solution for injection in a vial
EU/1/97/030/032
Insulin human Sanofi-Aventis Deutschland GmbH โ€”
Mixtard
EU/1/02/231/003-35,37
Insulin human, Insulin human Novo Nordisk A/S โ€”
Mixtard
EU/1/02/231/1-25
Insulin human Novo Nordisk A/S Not marketed
Protaphane
EU/1/02/234/016-017
Insulin human Novo Nordisk A/S โ€”
Protaphane
EU/1/02/234/1-15
Insulin human Novo Nordisk A/S โ€”
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 13 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.